| 000 | 01606 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250518034951.0 | ||
| 264 | 0 | _c20200303 | |
| 008 | 202003s 0 0 eng d | ||
| 022 | _a1873-7064 | ||
| 024 | 7 |
_a10.1016/j.neuropharm.2019.04.022 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhu, Xia | |
| 245 | 0 | 0 |
_aThe antidepressant- and anxiolytic-like effects of resveratrol: Involvement of phosphodiesterase-4D inhibition. _h[electronic resource] |
| 260 |
_bNeuropharmacology _c07 2019 |
||
| 300 |
_a20-31 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdaptor Proteins, Signal Transducing _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Anxiety Agents _xpharmacology |
| 650 | 0 | 4 |
_aAntidepressive Agents _xpharmacology |
| 650 | 0 | 4 |
_aCytoskeletal Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMaze Learning _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred ICR |
| 650 | 0 | 4 |
_aPhosphodiesterase 4 Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 |
_aResveratrol _xpharmacology |
| 700 | 1 | _aLi, Wenhua | |
| 700 | 1 | _aLi, Yongkun | |
| 700 | 1 | _aXu, Wenhua | |
| 700 | 1 | _aYuan, Yirong | |
| 700 | 1 | _aZheng, Victor | |
| 700 | 1 | _aZhang, Hanting | |
| 700 | 1 | _aO'Donnell, James M | |
| 700 | 1 | _aXu, Ying | |
| 700 | 1 | _aYin, Xiaoxing | |
| 773 | 0 |
_tNeuropharmacology _gvol. 153 _gp. 20-31 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.neuropharm.2019.04.022 _zAvailable from publisher's website |
| 999 |
_c29629175 _d29629175 |
||